Patents by Inventor Kokichi HONDA

Kokichi HONDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10881734
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: January 5, 2021
    Assignee: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Chigusa Yoshimura, Reimi Kawaida, Kokichi Honda
  • Publication number: 20200085946
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Application
    Filed: November 19, 2019
    Publication date: March 19, 2020
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Chigusa YOSHIMURA, Reimi KAWAIDA, Kokichi HONDA
  • Patent number: 10478496
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: November 19, 2019
    Assignee: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Chigusa Yoshimura, Reimi Kawaida, Kokichi Honda
  • Publication number: 20180133314
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Application
    Filed: April 19, 2016
    Publication date: May 17, 2018
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Chigusa YOSHIMURA, Reimi KAWAIDA, Kokichi HONDA